Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France

NCT06157086 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis (MS)

Interventions

OTHER: ofatumumab

Sponsor

Novartis Pharmaceuticals